LunarCrush LLM | post/tweet::1946977753703551471

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AponiaAnalytics Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1816152863069925376.png) aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4964 followers
Created: 2025-07-20 16:57:24 UTC

🦉 Twelve percent of U.S. adults have used GLP-1 agonists like semaglutide or tirzepatide. A new 6-month University of Melbourne trial will use MRIs to evaluate brain changes in adults with BED taking GLP-1s. All subjects receive concurrent psychotherapy. GLP-1s are not yet approved for BED.
#GLP1 #Tirzepatide $NVO $LLY


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946977753703551471/c:line.svg)

**Related Topics**
[$lly](/topic/$lly)
[melbourne](/topic/melbourne)
[$nvo](/topic/$nvo)
[stocks healthcare](/topic/stocks-healthcare)
[eli lilly](/topic/eli-lilly)

[Post Link](https://x.com/AponiaAnalytics/status/1946977753703551471)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

aponia_analytics @AponiaAnalytics on x 4964 followers Created: 2025-07-20 16:57:24 UTC

🦉 Twelve percent of U.S. adults have used GLP-1 agonists like semaglutide or tirzepatide. A new 6-month University of Melbourne trial will use MRIs to evaluate brain changes in adults with BED taking GLP-1s. All subjects receive concurrent psychotherapy. GLP-1s are not yet approved for BED. #GLP1 #Tirzepatide $NVO $LLY

XX engagements

Engagements Line Chart

Related Topics $lly melbourne $nvo stocks healthcare eli lilly

Post Link